Literature DB >> 16374598

Severe creatine kinase increase during quetiapine and mirtazapine treatment.

Sule Apikoglu Rabus, Fikret Izzettin, Murat Rabus, Mustafa Bilici.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16374598     DOI： 10.1007/s00213-005-0273-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  8 in total

1.  Antipsychotic drugs, serum creatine kinase (CPK) and possible mechanisms.

Authors:  S Devarajan; S M Dursun
Journal:  Psychopharmacology (Berl)       Date:  2000-09       Impact factor: 4.530

2.  Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message?

Authors:  H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2000-06       Impact factor: 4.530

3.  Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine.

Authors:  E Boot; L de Haan
Journal:  Psychopharmacology (Berl)       Date:  2000-06       Impact factor: 4.530

4.  Olanzapine elevation of serum creatine kinase.

Authors:  Ezequiel Martí-Bonmatí; Eva San Valero-Carcelén; María Pilar Ortega-García; Ricardo Rubini-Puig
Journal:  J Clin Psychiatry       Date:  2003-04       Impact factor: 4.384

5.  Severe elevations in serum creatine kinase associated with clozapine.

Authors:  J I Kirson; H L McQuistion; D W Pierce
Journal:  J Clin Psychopharmacol       Date:  1995-08       Impact factor: 3.153

6.  Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment.

Authors:  H Y Meltzer; P A Cola; M Parsa
Journal:  Neuropsychopharmacology       Date:  1996-10       Impact factor: 7.853

7.  Creatine kinase elevations with clozapine.

Authors:  M S Keshavan; J Stecker; R K Kambhampati
Journal:  Br J Psychiatry       Date:  1994-01       Impact factor: 9.319

8.  Marked elevation of serum creatine kinase associated with olanzapine therapy.

Authors:  E L Marcus; A Vass; J Zislin
Journal:  Ann Pharmacother       Date:  1999-06       Impact factor: 3.154
  8 in total
  2 in total

1.  Acute rhabdomyolysis during treatment with amisulpride and metformin.

Authors:  Francesco Ursini; Elena Succurro; Alessandro Grembiale; Franco Arturi
Journal:  Eur J Clin Pharmacol       Date:  2009-12-18       Impact factor: 2.953

Review 2.  Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice.

Authors:  Zacharias G Laoutidis; Kanellos T Kioulos
Journal:  Psychopharmacology (Berl)       Date:  2014-10-16       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.